As people with type 2 diabetes form a heterogeneous group, treatment regimens and
therapeutic targets should be individualized. As type 2 diabetes is characterized by insulin …

In Canada, there is a care gap between the clinical goals outlined in evidence-based
guidelines for diabetes management and actual clinical practice 1, 2. Since almost 80% of the …

In Canada, there is a care gap between the clinical goals outlined in evidence-based
guidelines for diabetes management and real-life clinical practice 1, 2. Since almost 80% of the …

Diabetes increases the risk for disorders that predispose individuals to hospitalization, including
cardiovascular disease, nephropathy, infection, cancer and lower-extremity amputations…

The process of the development of the Canadian Diabetes Association 2013 Clinical
Practice Guidelines for the Prevention and Management of Diabetes in Canada included …

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for
management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia …

Discussion This report illustrates an atypical case of DKA with only minor hyperglycemia in
a patient taking an SGLT2 inhibitor for what appeared to be T2DM. There are several factors …

Since the first big landmark trial on glycemic control and complications in type 1 diabetes (DCCT
[Diabetes Control and Complications Trial]) 1 was published in 1993, almost every …

Diabetes in long-term care is increasing in prevalence. This population of the frail elderly
presents unique challenges in terms of barriers to care, pharmacologic management, glycemic …

Objectives To observe the effect of an organization-of-care improvement process on the
achievement of therapeutic goals for people with type 2 diabetes mellitus (T2DM). Methods This …